NCT07060248View on ClinicalTrials.gov

A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.

Active, not recruitingOBSERVATIONAL

Enrollment

700

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions

Renal Cell Carcinoma (RCC)

Trial Locations (1)

Unknown

Second Xiangya Hospital, Changsha

All Listed Sponsors

lead

Second Xiangya Hospital of Central South University

OTHER